A substantially purified interleukin-1 inhibitor (IL-li which is active against interleukin-1 alpha or interleukin-1 beta or both of these substances. A recombinant-DNA method for the production of an interleukin-1 inhibitor (IL-li), and an isolated DNA sequence encoding a physiologically functional interleukin-1 inhibitor (IL-li). <IMAGE>
申请公布号
DE68929387(D1)
申请公布日期
2002.05.16
申请号
DE1989629387
申请日期
1989.05.26
申请人
AMGEN INC., THOUSAND OAKS;UNIVERSITY OF COLORADO FOUNDATION, INC.
发明人
HANNUM, CHARLES H.;EISENBERG, STEPHAN P.;THOMPSON,ROBERT C.;AREND, WILLIAM P.;JOSLIN,FENNEKE G.;SOMMER, ANDREAS
